AstraZeneca Pharma India receives CDSCO approval for Trastuzumab Deruxtecan for additional cancer indications https://english.mathrubhumi.com/news/india/astrazeneca-cancer-drug-india-approval-ojvxhabc?utm_source=dlvr.it&utm_medium=mastodon #astrazeneca #pharmaindia #cdsco #cancer
